Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biogen Pharmachem Industries has allotted 15,04,33,833 bonus equity shares to existing shareholders. This increased the company's paid-up capital from Rs. 90.26 crore (90.26 crore shares of Rs. 1 each) to Rs. 105.30 crore (105.30 crore shares of Rs. 1 each). The bonus was approved in a Board allotment meeting held on May 18, 2026, and shares were credited to shareholders on the same date. The bonus ratio works out to approximately 1:6 (one bonus share for every six shares held), expanding the capital base by roughly 16.67%.
Bonus issues increase share quantity but maintain total value, typically leading to a proportional price adjustment. The 1:6 ratio is modest and signals management confidence in future prospects, though immediate price impact depends on market sentiment.